Acyclovir and Midostaurin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Acyclovir (acyclovir) and Midostaurin (midostaurin). Common drug interactions include acute myeloid leukaemia recurrent among females and pneumonia among males.
The phase IV clinical study analyzes what interactions people have when they take Acyclovir and Midostaurin. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.
What is Acyclovir?
Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.
What is Midostaurin?
Midostaurin has active ingredients of midostaurin. eHealthMe is studying from 1,137 Midostaurin users. Check the latest studies of Midostaurin.
19 people who take Acyclovir and Midostaurin together, and have interactions are studied.

What are the common drug interactions of Acyclovir and Midostaurin, by gender? *:
female:
- Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
- Anaemia macrocytic (a macrocytic class of anaemia)
- Asthenia (weakness)
- Blood alkaline phosphatase increased
- Constipation
- Febrile neutropenia (fever with reduced white blood cells)
- Haematochezia (passage of stools containing blood)
- Neoplasm progression (growth of tumour)
- Neutropenia (an abnormally low number of neutrophils)
- Neutropenic colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition)
male:
- Pneumonia
- Stenotrophomonas infection
- Aplasia (defective development or congenital absence of an organ or tissue)
- Bone marrow failure
- Infection
- Sepsis (a severe blood infection that can lead to organ failure and death)
What are the common drug interactions of Acyclovir and Midostaurin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Diarrhoea
- Nausea (feeling of having an urge to vomit)
- Vomiting
- Asthenia (weakness)
- Febrile neutropenia (fever with reduced white blood cells)
- Haematochezia (passage of stools containing blood)
- Pharyngitis (inflammation of the pharynx, causing a sore throat)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Septic shock (shock due to blood infection)
40-49:
- Hyperbilirubinaemia (excess of bilirubin in the blood)
- Infection
- Neoplasm progression (growth of tumour)
- Neutropenic colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition)
- Sepsis (a severe blood infection that can lead to organ failure and death)
50-59:
- Pneumonia
- Stenotrophomonas infection
- Aplasia (defective development or congenital absence of an organ or tissue)
- Bone marrow failure
60+:
- Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
- Anaemia macrocytic (a macrocytic class of anaemia)
- Blood alkaline phosphatase increased
- Constipation
- Diarrhoea
- Nausea (feeling of having an urge to vomit)
- Neutropenia (an abnormally low number of neutrophils)
- Pericardial effusion (fluid around the heart)
- Pleural effusion (water on the lungs)
- Thrombocytopenia (decrease of platelets in blood)
What are the existing conditions these people have? *
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 17 people, 89.47%
- Infection: 5 people, 26.32%
- Proctitis (inflammation of the rectum and anus): 2 people, 10.53%
- Febrile Neutropenia (fever with reduced white blood cells): 2 people, 10.53%
- Blood Albumin Decreased: 2 people, 10.53%
- Stress And Anxiety: 1 person, 5.26%
- Septic Shock (shock due to blood infection): 1 person, 5.26%
- Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 5.26%
- Nausea And Vomiting: 1 person, 5.26%
- Nausea (feeling of having an urge to vomit): 1 person, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Acyclovir and Midostaurin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Acyclovir (54,961 reports)
- Midostaurin (1,137 reports)
Browse all drug interactions of Acyclovir and Midostaurin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Acyclovir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Midostaurin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Acyclovir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Midostaurin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Choi N, Lee JY, Sunwoo JS, Kwon KI, Roh H, Ahn MY, Lee KB, "Hyponatremia during Acyclovir Treatment of Bell’s Palsy", Journal of the Korean Neurological Association, 2017 Aug .
- Choi N, Lee JY, Sunwoo JS, Kwon KI, Roh H, Ahn MY, Lee KB, "Hyponatremia during Acyclovir Treatment of Bell’s Palsy", Journal of the Korean Neurological Association, 2017 Aug .
How the study uses the data?
The study uses data from the FDA. It is based on acyclovir and midostaurin (the active ingredients of Acyclovir and Midostaurin, respectively), and Acyclovir and Midostaurin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Myocarditis and drugs of ingredients of tretinoin - 4 seconds ago
- Drug interactions of Temazepam and Timolol - 9 seconds ago
- Could Altace cause Psychomotor Hyperactivity? - 9 seconds ago
- Montelukast Sodium and Respiratory Disorder for Women aged 50-59 - 20 seconds ago
- Dasatinib and Fever for Women aged 20-29 - 26 seconds ago
- Dasatinib and Heat Stroke for Women aged 20-29 - 26 seconds ago
- Dasatinib and Body Overheating for Women aged 20-29 - 27 seconds ago
- Dasatinib and Pyrexia for Women aged 20-29 - 27 seconds ago
- Dasatinib and Hyperthermia for Women aged 20-29 - 27 seconds ago
- Dasatinib and Elevated Temperature for Women aged 20-29 - 28 seconds ago